In both 2001 and 2004, Kim et al. and Gould et al., respectively, demonstrated that MYOC mutations are gain-of-function mutations, as neither KO nor transgenic Myoc mouse model did not lead to a glaucoma phenotype or elevated IOP [114,118]. The gene discussed is MYOC; the disease is glaucoma.